nitroglycerin has been researched along with bay-k-8644 in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (42.86) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Howlett, SE; Knaus, EE; Shan, R | 1 |
Carbone, E; Di Stilo, A; Fruttero, R; Gasco, A; Novara, M; Rolando, B; Roussel, C; Vanthuyne, N; Visentin, S | 1 |
Katayose, D; Ogata, M; Ohe, M; Takishima, T | 1 |
Abraham, S; Amitai, G; Oz, N; Weissman, BA | 1 |
Ishii, K; Sato, Y; Taira, N | 1 |
Hyman, AL; Kadowitz, PJ; Lippton, HL | 1 |
Kubo, T; Taguchi, K; Ueda, M | 1 |
7 other study(ies) available for nitroglycerin and bay-k-8644
Article | Year |
---|---|
Syntheses, calcium channel agonist-antagonist modulation activities, nitric oxide release, and voltage-clamp studies of 2-nitrooxyethyl 1,4-dihydro- 2,6-dimethyl-3-nitro-4-(2-trifluoromethylphenyl)pyridine-5-carboxylate enantiomers.
Topics: Animals; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Female; Guinea Pigs; Ileum; In Vitro Techniques; Magnetic Resonance Spectroscopy; Male; Muscle, Smooth; Myocardium; Nicotinic Acids; Nitric Oxide; Patch-Clamp Techniques; Pyridines; Stereoisomerism | 2002 |
New 1,4-dihydropyridines endowed with NO-donor and calcium channel agonist properties.
Topics: Animals; Aorta, Thoracic; Calcium Channels, L-Type; Cell Line, Tumor; Dihydropyridines; In Vitro Techniques; Male; Muscle, Smooth; Nitric Oxide Donors; Papillary Muscles; Patch-Clamp Techniques; Rats; Rats, Wistar; Stereoisomerism; Vasodilator Agents | 2004 |
Hypoxic contraction of pre-stretched human pulmonary artery.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adult; Aged; Arachidonic Acids; Culture Techniques; Humans; Lipoxygenase; Middle Aged; Nitroglycerin; Oxygen; Propranolol; Pulmonary Artery; Vasoconstriction; Verapamil | 1992 |
Bay K 8644-induced changes in the ECG pattern of the rat and their inhibition by antianginal drugs.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Atropine; Blood Pressure; Carotid Arteries; Diltiazem; Dose-Response Relationship, Drug; Electrocardiography; Injections, Intra-Arterial; Isoquinolines; Male; Nifedipine; Nitroglycerin; Phentolamine; Rats; Rats, Inbred Strains | 1987 |
Differential antagonism by Bay K 8644 of vasodilator effects of nifedipine, diltiazem, nicorandil and nitroglycerin in dog femoral circulation.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Diltiazem; Dogs; Dose-Response Relationship, Drug; Female; Femoral Artery; Femur; Male; Niacinamide; Nicorandil; Nifedipine; Nitroglycerin; Regional Blood Flow; Vasodilator Agents | 1988 |
Methylene blue selectively inhibits pulmonary vasodilator responses in cats.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Acetylcholine; Angiotensin II; Animals; Blood Pressure; Bradykinin; Cats; Cyclic GMP; Epinephrine; Female; Isoproterenol; Male; Methylene Blue; Nitroglycerin; Prostaglandin Endoperoxides, Synthetic; Pulmonary Artery; Pulmonary Circulation; Reference Values; Vasodilation | 1989 |
Effects of cAMP and cGMP on L-type calcium channel currents in rat mesenteric artery cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Bucladesine; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Colforsin; Cyclic AMP; Cyclic GMP; In Vitro Techniques; Isoquinolines; Male; Membrane Potentials; Mesenteric Arteries; Muscle, Smooth, Vascular; Nifedipine; Nitroglycerin; Patch-Clamp Techniques; Rats; Rats, Wistar | 1997 |